{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:49Z","timestamp":1786120309155,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/iae.0b013e31822c28d6","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T04:08:30Z","timestamp":1323144510000},"page":"967-971","source":"Crossref","is-referenced-by-count":26,"title":["EFFECT OF INTRAVITREAL BEVACIZUMAB ON RETROBULBAR BLOOD FLOW IN INJECTED AND UNINJECTED FELLOW EYES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"32","author":[{"given":"Hamid","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina Heidari","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Razeghinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouros","family":"Nouri-Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Anti-vascular endothelial growth factor therapy for ocular neovascular disease.","volume":"18","author":"Andreoli","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/bjo.2008.141721","article-title":". A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"92","author":"Arias","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ICU.0b013e32832d25b3","article-title":"Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.","volume":"20","author":"Ciulla","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ophtha.2009.07.023","article-title":"Intravitreal bevacizumab and ranibizumab for age-related macular degeneration: a multicenter, retrospective study.","volume":"117","author":"Fong","year":"2010","journal-title":"Ophthalmology"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/ICU.0b013e328329b656","article-title":"Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration.","volume":"20","author":"Jeganathan","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/eye.2009.219","article-title":"Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature.","volume":"24","author":"Jyothi","year":"2009","journal-title":"Eye"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-57","article-title":". Hemorrhagic macular infarction after intravitreal bevacizumab for central retinal vein occlusion.","volume":"9","author":"Furino","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00417-009-1184-5","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.","volume":"247","author":"Ganssauge","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/WNO.0b013e3181a58fd1","article-title":"Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab.","volume":"29","author":"Hosseini","year":"2009","journal-title":"J Neuroophthalmol"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000235726","article-title":". Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome.","volume":"224","author":"Huang","year":"2009","journal-title":"Ophthalmologica"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1755-3768.2008.01175.x","article-title":"Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to nonischaemic central retinal vein occlusion.","volume":"86","author":"Kim","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1755-3768.2009.01535.x","article-title":". Retinal vascular events after intravitreal bevacizumab.","volume":"88","author":"Mansour","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1755-3768.2008.01187.x","article-title":". Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma.","volume":"86","author":"Yokoyama","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.ophtha.2009.03.017","article-title":". Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.","volume":"116","author":"Papadopoulou","year":"2009","journal-title":"Ophthalmology"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0420.2007.01057.x","article-title":". Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema.","volume":"86","author":"Soliman","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00417-005-0201-6","article-title":". Association between systemic arterial stiffness and age-related macular degeneration.","volume":"244","author":"Sato","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1755-3768.2009.01526.x","article-title":". Ultrasound assessment of short term ocular vascular effects of intravitreal injection of bevacizumab (Avastin) in neovascular age related macular degeneration.","volume":"88","author":"Bonnin","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jcu.20650","article-title":"Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age related macular degeneration.","volume":"38","author":"Mete","year":"2010","journal-title":"J Clin Ultrasound"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7863\/jum.1995.14.2.91","article-title":"Color Doppler imaging of the eye: normal ranges, reproducibility, and observer variation.","volume":"14","author":"Baxter","year":"1995","journal-title":"J Ultrasound Med"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1755-3768.1992.tb04924.x","article-title":"Color Doppler imaging of the eye and orbit: a synopsis of a 400 case experience.","volume":"70","author":"Lieb","year":"1992","journal-title":"Acta Ophthalmol"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0039-6257(96)82001-7","article-title":"Color Doppler ultrasound imaging of the eye and orbit.","volume":"40","author":"Williamson","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archopht.1991.01080040095036","article-title":". Color Doppler imaging of the eye and orbit: technique and normal vascular anatomy.","volume":"109","author":"Lieb","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/bjo.80.12.1055","article-title":". Acute IOP elevation with scleral suction: effects on retrobulbar haemodynamics.","volume":"80","author":"Harris","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"R27-14-20210130","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":". Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R28-14-20210130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaapos.2009.03.006","article-title":"Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema.","volume":"13","author":"Al-Dhibi","year":"2009","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"R29-14-20210130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0003-4975(01)03404-X","article-title":". Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery.","volume":"73","author":"Liu","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R30-14-20210130","first-page":"2228","article-title":". Nitric oxide controls arteriolar tone in the retina of the miniature pig.","volume":"36","author":"Donati","year":"1995","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"R31-14-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.vph.2006.10.009","article-title":". Vasorelaxation induced by vascular endothelial growth factor in the human internal mammary artery and radial artery.","volume":"46","author":"Wei","year":"2007","journal-title":"Vascul Pharmacol"},{"key":"R32-14-20210130","doi-asserted-by":"crossref","first-page":"H547","DOI":"10.1152\/ajpheart.00616.2005","article-title":". Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling.","volume":"290","author":"Baffert","year":"2006","journal-title":"Am J Physiol Heart Circul Physiol"},{"key":"R33-14-20210130","doi-asserted-by":"crossref","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","article-title":". VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.","volume":"290","author":"Kamba","year":"2006","journal-title":"Am J Physiol Heart Circul Physiol"},{"key":"R34-14-20210130","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI24612","article-title":". Rapid vascular regrowth in tumors after reversal of VEGF inhibition.","volume":"116","author":"Mancuso","year":"2006","journal-title":"J Clin Investig"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201205000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:06Z","timestamp":1786048146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201205000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31822c28d6","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}